Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction
Open Access
- 27 January 2020
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 43 (2) , 568-578
Abstract
: Impaired intestinal mucosal integrity during colitis involves the peroxisome proliferator-activated receptor-γ (PPARγ), an important anti-inflammatory factor in intestinal mucosa homoeostasis, which is a potential target in colitis. Recurrent chronic pain is a vital pathogenetic feature of colitis. Nevertheless, potential functions of PPARγ in the colitis-associated hyperalgesia remain unclear. This study aimed to investigate biological roles of pioglitazone in relieving colitis-associated pain hypersensitivity by a PPARγ tight junction protein-dependent mechanism during the course of dextran sodium sulfate (DSS)-induced intestinal inflammation. The DSS-induced colitis model was generated in C57BL/6 mice. Changes in colitis induced the injury of intestinal mucosal barrier and hyperalgesia after a 6-day treatment of pioglitazone (25 mg/kg, IP injection) were assessed through immunofluorescent, hematoxylin and eosin (H&E) staining, western blot analysis, and determination of paw withdrawal mechanical threshold. A significant reduction of paw withdrawal mechanical threshold occurred after DSS treatment. Follow-up data showed that systematic administration of PPARγ agonist pioglitazone ameliorated the DSS-induced colitis and the development of colitis-associated hyperalgesia by repairing the intestinal mucosal barrier. The tight junction proteins ZO-1 and Claudin-5 were upregulated by PPARγ signaling, which in turn promoted the improvement of intestinal barrier function. Moreover, pioglitazone inhibited phosphorylation of ERK and NF-κB in the colon and decreased the levels of inflammatory cytokines in both colon spine tissues. Furthermore, systemically pioglitazone treatment inhibited the activation of microglia and astrocytes, as well as DSS-induced phosphorylation of NR2B subunit in spinal cord, which was correspondingly consistent with the pain behavior. Pioglitazone ameliorates DSS-induced colitis and attenuates colitis-associated mechanical hyperalgesia, with improving integrity of the intestinal mucosal barrier by directly upregulating tight junction proteins. The PPARγ-tight junction protein signaling might be a potential therapeutic target for the treatment of colitis-associated chronic pain.Keywords
Funding Information
- National Natural Science Foundation of China (81671087, 81471129, 81870871, 81500954)
- Key Technologies Research and Development Program (SQ2018YFC200044)
This publication has 53 references indexed in Scilit:
- Neuroanatomy of lower gastrointestinal pain disordersWorld Journal of Gastroenterology, 2014
- MicroRNA-124 Regulates STAT3 Expression and Is Down-regulated in Colon Tissues of Pediatric Patients With Ulcerative ColitisGastroenterology, 2013
- Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase-1 in macrophagesPain, 2013
- Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human GeneticsFrontiers in Immunology, 2013
- β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ PathwayThe American Journal of Pathology, 2011
- Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel diseaseMucosal Immunology, 2010
- Gut, inflammation and osteoporosis: basic and clinical conceptsGut, 2008
- Intestinal Antiinflammatory Effects of Thiazolidenedione Peroxisome Proliferator-Activated Receptor-γ Ligands on T Helper Type 1 Chemokine Regulation Include Nontranscriptional Control MechanismsInflammatory Bowel Diseases, 2005
- Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-κB-cytokine cascadeRedox Report, 2002
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994